HFA-ICOS Cardio-Oncology Risk: CML Kinase Inhibitors
TKI cardiotoxicity in CML (educational reference).
Calculator
How it works
HFA-ICOS Cardio-Oncology Risk: CML Kinase Inhibitors — educational reference for clinicians and trainees.
Limits
Simplified tool; use institutional protocols.
Educational tool only—not for diagnosis or treatment decisions.